Lorea Mar-Barrutia
Overview
Explore the profile of Lorea Mar-Barrutia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Segura A, Prohens L, Julia L, Amoretti S, RIbero M, Pino-Camacho L, et al.
Eur Neuropsychopharmacol
. 2025 Feb;
94:4-15.
PMID: 39956014
Both genetic and environmental factors have been found to play a significant role in psychosis relapse, either independently or through their synergistic interaction. Recently, DNA methylation (DNAm) has been proposed...
2.
Mar J, Zubiagirre U, Larranaga I, Soto-Gordoa M, Mar-Barrutia L, Gonzalez-Pinto A, et al.
J Alzheimers Dis
. 2024 Jun;
100(2):645-655.
PMID: 38943388
Background: Antipsychotics are widely used in the elderly due to the high prevalence of neuropsychiatric associated with dementia. Objective: To analyze potential disparities in antipsychotic use in the general population...
3.
Pemau A, Marin-Martin C, Diaz-Marsa M, de la Torre-Luque A, Ayad-Ahmed W, Gonzalez-Pinto A, et al.
Psychol Med
. 2024 Apr;
54(9):1897-1904.
PMID: 38623694
Background: Suicide is one of the main external causes of death worldwide. People who have already attempted suicide are at high risk of new suicidal behavior. However, there is a...
4.
De la Pena-Arteaga V, Cano M, Porta-Casteras D, Vicent-Gil M, Miquel-Giner N, Martinez-Zalacain I, et al.
Eur Neuropsychopharmacol
. 2024 Mar;
82:72-81.
PMID: 38503084
Mindfulness-based cognitive therapy (MBCT) stands out as a promising augmentation psychological therapy for patients with obsessive-compulsive disorder (OCD). To identify potential predictive and response biomarkers, this study examines the relationship...
5.
Zubiagirre U, Ibarrondo O, Larranaga I, Soto-Gordoa M, Mar-Barrutia L, Mar J
BMC Geriatr
. 2024 Feb;
24(1):209.
PMID: 38424518
Background: Low household income (HI), comorbidities and female sex are associated with an increased risk of dementia. The aim of this study was to measure the mediating effect of comorbidity...
6.
Mar-Barrutia L, Ibarrondo O, Mar J, Real E, Segalas C, Bertolin S, et al.
Span J Psychiatry Ment Health
. 2024 Feb;
PMID: 38331320
Introduction: Deep brain stimulation (DBS) is an effective alternative to treat severe refractory obsessive-compulsive disorder (OCD), although little is known on factors predicting response. The objective of this study was...
7.
Chart-Pascual J, Montero-Torres M, Ortega M, Mar-Barrutia L, Zorrilla Martinez I, Alvarez-Mon M, et al.
J Affect Disord
. 2024 Jan;
351:649-660.
PMID: 38290587
Background: Severe mental disorders like Schizophrenia and related psychotic disorders (SRD) or Bipolar Disorder (BD) require pharmacological treatment for relapse prevention and quality of life improvement. Yet, treatment adherence is...
8.
Larranaga I, Ibarrondo O, Mar-Barrutia L, Soto-Gordoa M, Mar J
Cost Eff Resour Alloc
. 2023 Mar;
21(1):18.
PMID: 36859271
Background: Mental illnesses account for a considerable proportion of the global burden of disease. Economic evaluation of public policies and interventions aimed at mental health is crucial to inform decisions...
9.
Mar J, Ibarrondo O, Larranaga I, Mar-Barrutia L, Soto-Gordoa M
Alzheimers Res Ther
. 2022 Nov;
14(1):171.
PMID: 36371267
Introduction: The effectiveness, safety, and cost-effectiveness of the use of Souvenaid for Alzheimer's disease (AD) have been previously evidenced. To complete the economic analysis, there is a need to assess...
10.
Mar J, Gorostiza A, Arrospide A, Larranaga I, Alberdi A, Cernuda C, et al.
Rev Psiquiatr Salud Ment (Engl Ed)
. 2022 Oct;
15(3):167-175.
PMID: 36272739
Introduction: Incidence rates of dementia-related neuropsychiatric symptoms (NPS) are not known and this hampers the assessment of their population burden. The objective of this study was to obtain an approximate...